QT interval prolongation and with donepezil, rivastigmine and galantamine
Background: Acetylcholinesterase inhibitors (AChEis) including donepezil, galantamine and rivastigmine are used to treat Alzheimer’s disease (AD). This study aimed to evaluate evidence from the case report literature for an association between these agents and risk of QT interval prolongation and To...
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
SAGE Publishing
2020-08-01
|
| Serie: | Therapeutic Advances in Drug Safety |
| Länkar: | https://doi.org/10.1177/2042098620942416 |